• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Hookipa CEO waives 50% of salary in bet on brighter days

cafead

Administrator
Staff member
  • cafead   Mar 24, 2022 at 11:53: AM
via Hookipa Pharma CEO Joern Aldag is betting on brighter days for biotech. With Hookipa’s stock stuck in the doldrums, Aldag is waiving 50% of his salary over the first half of the year in return for shares in a show of confidence in the company.

article source